Grigeo Tissue - Company finances
|
EUR
|
2023
From: 2023-12-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 6,469 | 58,784,252 | 98,163,859 |
| Profit before tax | -69,794 | 5,707,495 | 8,408,341 |
| Net profit | -59,325 | 4,453,773 | 7,435,268 |
| Equity | 140,675 | 80,403,494 | 80,714,599 |
| Liabilities | 111,276 | 12,854,248 | 17,110,508 |
| Non-current assets | 48,179 | 72,961,387 | 78,635,572 |
| Current assets | 203,772 | 27,949,329 | 26,672,022 |
| Total assets | 251,951 | 100,910,716 | 105,307,594 |
|
Taxes paid
|
|||
| STI taxes | 1,006 | 508,143 | 2,540,046 |
| Social insurance contributions | - | 1,348,747 | 2,336,016 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +908606.9% | +67.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -23.5% | 4.4% | 7.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -42.2% | 5.5% | 9.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -917.1% | 7.6% | 7.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -1078.9% | 9.7% | 8.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.8 | 0.2 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 360,824 | 390,443 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Grigeo Tissue - Social security debts
The company had no debts to Sodra
Grigeo Tissue - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Grigeo Tissue, UAB (company code 306639125) is a Private Limited Liability Company engaged in the manufacture of household and sanitary goods and of toilet requisites. In 2025, the company generated revenue of €98.16M and net profit of €7.44M, with a profit margin of 7.6%. This followed revenue of €58.78M and net profit of €4.45M in 2024, indicating continued strong expansion and improved earnings. The 2023 figure covers a 30-day period and shows only €6.5K of revenue and a net loss of €59.3K, so the longer-term comparison should be read with caution. At the end of 2025, total assets stood at €105.31M, equity at €80.71M and liabilities at €17.11M, leaving a solid equity base and moderate leverage. Long-term assets amounted to €78.64M and short-term assets to €26.67M. Key ratios for 2025 were ROE of 9.2%, ROA of 7.1%, debt-to-equity of 0.21 and asset turnover of 0.93x. Revenue per employee was €391.1K and profit per employee was €29.6K, reflecting efficient output.